Siemens Healthcare Diagnostics’ Dr David Stein, CEO, Point of Care Business Unit, shared his perspective on blood gas testing and the technology’s future, in this interview.

Stein says end-to-end harmonization is a key pillar of Siemens’s point-of-care-testing (POCT) strategy because “harmonization helps to ensure that the same clinical decisions are made for the patient, regardless of which Siemens blood gas system performed the test and where, so that appropriate and consistent therapeutic actions are administered.”

Stein also explained the shift towards POCT and the company’s plans for the future.